Efficacy and safety of umbilical cord mesenchymal stem cells for the treatment of patients with COVID-19
2021 · Clinics · 29 citations
https://doi.org/10.6061/clinics/2021/e2604
D
Dexiao Kong
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
28
Papers
295
Citations
9
h-index
9
i10-index
Dexiao Kong is an academic researcher from Second Hospital of Shandong University. The author has contributed to research in topics: Mesenchymal stem cell research & Immune Cell Function and Interaction & Multiple Myeloma Research and Treatments. The author has an h-index of 9, co-authored 24 publications.
ORCID: 0000-0001-7339-3560Papers by this author
worksRest-activity rhythms and tract specific white matter lesions in older adults at risk for cognitive decline
2022 · Molecular Psychiatry · 12 citations
https://doi.org/10.1038/s41380-022-01641-4
Irisin protected hemopoietic stem cells and improved outcome of severe bone marrow failure
2023 · Biomedicine & Pharmacotherapy · 5 citations
https://doi.org/10.1016/j.biopha.2023.115863
Uncovering the cellular and omics characteristics of natural killer cells in the bone marrow microenvironment of patients with acute myeloid leukemia
2024 · Cancer Cell International · 2 citations
https://doi.org/10.1186/s12935-024-03300-w
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat